Author details

Full Name

Nicholas A Vitanza

Affiliation

ORCID

Career Start Year

2014

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37541803	CAR T cell therapies for diffuse midline glioma.		2023
35605606	Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.	Neuro Oncol	2023
36259971	Intraventricular B7-H3 CAR T Cells for Diffuse Intrinsic Pontine Glioma: Preliminary First-in-Human Bioactivity and Safety.	Cancer Discov	2023
37603953	Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma.	Neoplasia	2023
37160547	Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data.	Curr Oncol Rep	2023
36912520	Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor (CAR) T Cell Infusions in Mice.	J Vis Exp	2023
37024595	Tumor inflammation-associated neurotoxicity.	Nat Med	2023
36711964	Functional genomic analysis of adult and pediatric brain tumor isolates.	bioRxiv	2023
37145169	ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma.	Cancer Res	2023
37195023	ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma.	Cancer Res	2023
37244226	Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology.	Neoplasia	2023
37232001	A Comparison of Clinical Outcomes for Subependymal Giant Cell Astrocytomas Treated with Laser Interstitial Thermal Therapy, Open Surgical Resection, and mTOR Inhibitors.	Pediatr Neurosurg	2023
36599192	Locoregional CAR T cells for children with CNS tumors: Clinical procedure and catheter safety.	Neoplasia	2023
35137228	Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma.	Neuro Oncol	2022
35481923	The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies.	Neuro Oncol	2022
36382108	Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy.	Neurooncol Adv	2022
35235780	dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region.	Cell Rep	2022
34850171	Radiomic signatures of posterior fossa ependymoma: Molecular subgroups and risk profiles.	Neuro Oncol	2022
35157764	Imipridones affect tumor bioenergetics and promote cell lineage differentiation in diffuse midline gliomas.	Neuro Oncol	2022
35129878	Two cases of pineal anlage tumor with molecular analysis.	Pediatr Blood Cancer	2022
34759345	Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies.	Oncogene	2022
34392363	Machine Assist for Pediatric Posterior Fossa Tumor Diagnosis: A Multinational Study.	Neurosurgery	2021
34224367	Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma.	Mol Cancer Ther	2021
34266866	Radiomic Phenotypes Distinguish Atypical Teratoid/Rhabdoid Tumors from Medulloblastoma.	AJNR Am J Neuroradiol	2021
34253928	Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis.	Nat Med	2021
33977272	MRI-based radiomics for prognosis of pediatric diffuse intrinsic pontine glioma: an international study.	Neurooncol Adv	2021
33031159	Extramedullary Hematopoiesis in the Dura Mater During Treatment of a CNS Embryonal Tumor.	Journal of Pediatric Hematology/Oncology	2021
32862234	Molecularly Targeted Treatments for NF1-Mutant Diffuse Intrinsic Pontine Glioma.	J Appl Lab Med	2021
33130903	Optimal therapeutic targeting by HDAC inhibition in biopsy-derived treatment-naÃ¯ve diffuse midline glioma models.	Neuro Oncol	2021
33235157	Care Coordination in a SARS-CoV-2-infected Child With Newly Diagnosed Medulloblastoma and Fanconi Anemia.	Journal of Pediatric Hematology/Oncology	2021
33225764	Considerations when treating high-grade pediatric glioma patients with immunotherapy.	Expert Rev Neurother	2021
34988452	Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma.	Neurooncol Adv	2021
32902381	Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones.	Elife	2020
31896081	Progress in diffuse intrinsic pontine glioma: advocating for stereotactic biopsy in the standard of care.	Neurosurgical Focus	2020
32297094	Intracranial growing teratoma syndrome (iGTS): an international case series and review of the literature.	J Neurooncol	2020
33768215	A Protocol for the Generation of Treatment-naÃ¯ve Biopsy-derived Diffuse Intrinsic Pontine Glioma and Diffuse Midline Glioma Models.	J Exp Neurol	2020
32816765	Deep Learning for Pediatric Posterior Fossa Tumor Detection and Classification: A Multi-Institutional Study.	AJNR Am J Neuroradiol	2020
31327426	No Further Therapy.	International Journal of Radiation Oncology Biology Physics	2019
31748226	Therapeutic strategies for diffuse midline glioma from high-throughput combination drug screening.	Sci Transl Med	2019
31903167	EGFR806-CAR T cells selectively target a tumor-restricted EGFR epitope in glioblastoma.	Oncotarget	2019
32923855	Response to Pembrolizumab in a Patient With Xeroderma Pigmentosum and Advanced Squamous Cell Carcinoma.	JCO Precision Oncology	2019
30169876	Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy.	Neuro-Oncology	2019
30523141	MR Imaging-Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma.	AJNR Am J Neuroradiol	2019
31290035	Diffuse Intrinsic Pontine Glioma: From Diagnosis to Next-Generation Clinical Trials.	Current Treatment Options in Neurology	2019
29322843	Immunotherapy for brain tumors: understanding early successes and limitations.	Expert Review of Neurotherapeutics	2018
29171168	Pilocytic astrocytoma with leptomeningeal spread in a patient with incontinentia pigmenti presenting with unilateral nystagmus.	Pediatric Blood and Cancer	2018
28746860	Integrating RNA sequencing into neuro-oncology practice.	Transl Res	2017
28434841	Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma.	Cancer Cell	2017
28860053	Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors.	Transl Res	2017
23652864	Noncarboplatin-induced Sensorineural Hearing Loss in a Patient With an Intracranial Nongerminomatous Germ Cell Tumor.	Journal of Pediatric Hematology/Oncology	2016